Effect of bathing on infants receiving phototherapy for jaundice
Effect of Bathing on Physiological Parameters, Skin, Bilirubin and Comfort Levels in Infants Receiving Phototherapy
This study is testing if bathing can help improve the comfort and health of newborns with jaundice who are receiving light treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 1 Day to 28 Days |
| Sex | All |
| Sponsor | Selcuk University Academic / other |
| Locations | 1 site (Kütahya, Merkez) |
| Trial ID | NCT06819150 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate how bathing impacts physiological parameters, skin condition, bilirubin levels, and comfort in infants undergoing phototherapy for jaundice. Neonatal jaundice is common and can lead to serious health issues if untreated, making effective management crucial. The study will involve newborns who are stable and require phototherapy, assessing the potential benefits of bathing as an intervention to mitigate side effects associated with phototherapy. By monitoring heart rate, body temperature, oxygen saturation, and skin integrity, the researchers hope to provide insights into improving care for these vulnerable patients.
Who should consider this trial
Good fit: Ideal candidates are newborns born at 35-41 weeks gestation with indirect hyperbilirubinemia requiring phototherapy and stable vital signs.
Not a fit: Patients with ABO or Rh incompatibility, direct hyperbilirubinemia, congenital anomalies, or existing skin lesions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the comfort and skin health of infants undergoing phototherapy, potentially reducing side effects.
How similar studies have performed: While the approach of bathing infants during phototherapy is not widely studied, similar interventions have shown promise in improving comfort and skin integrity in other contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Born at 35-41 gestational weeks * Indirect hyperbilirubinaemia diagnosed at 24 hours of birth or more, * No health problems, * Indication for phototherapy treatment * Stable vital signs * Whose parents agreed to participate in the study Exclusion Criteria: * Newborns with ABO and Rh incompatibility, * Direct diagnosis of hyperbilirubinaemia, * Congenital anomaly, * With skin lesions
Where this trial is running
Kütahya, Merkez
- Kütahya Şehir Hospital — Kütahya, Merkez, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: Perihan B Çalışkan, MSc student — Selcuk University
- Study coordinator: Perihan B Çalışkan, MSc student
- Email: perihanbeyza99@gmail.com
- Phone: +90 5061626224
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.